Celularity (CELU) Operating Expenses (2019 - 2025)

Celularity (CELU) has reported Operating Expenses for 7 consecutive years, with $26.2 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Operating Expenses fell 4.56% year-over-year to $26.2 million in Q4 2025; TTM through Dec 2025 was $87.9 million, a 5.1% decrease from a year earlier, with the FY2025 full-year figure at $87.9 million, down 5.1% from the prior year.
• Operating Expenses was $26.2 million for Q4 2025 at Celularity, up from $18.2 million in the prior quarter.
• Over five years, Operating Expenses peaked at $103.0 million in Q3 2023 and troughed at -$13.4 million in Q4 2022.
• A 5-year average of $28.5 million and a median of $22.0 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses jumped 30542.6% in 2021 and tumbled 167.43% in 2022, its largest moves.
• Over 5 years, Operating Expenses stood at $19.8 million in 2021, then plunged by 167.43% to -$13.4 million in 2022, then jumped by 90.99% to -$1.2 million in 2023, then surged by 2378.64% to $27.4 million in 2024, then declined by 4.56% to $26.2 million in 2025.
• The last three Operating Expenses figures came in at $26.2 million (Q4 2025), $18.2 million (Q3 2025), and $21.6 million (Q2 2025), per Business Quant data.